The Eyes Have It: Pupil Dilation as a Novel Biomarker for Cognitive Effort in Aging and MCI
A recent study in Alzheimer’s & Dementia investigates the potential of pupil dilation (PD) as a non-invasive, easy-to-measure cognitive marker in aging and mild cognitive impairment (MCI). Researchers assessed PD during an oddball task and a Simon task in younger adults, older adults, and patients with MCI. The findings indicate that PD is a sensitive measure of attentional allocation and cognitive effort, with elevated PD responses to salient stimuli observed across groups, particularly in MCI patients with better attentional control. This research highlights a promising, objective tool for assessing subtle changes in cognitive function, offering a potential alternative to traditional assessments that can be challenging for individuals with neurodegenerative conditions.
Study Significance: For clinicians and researchers in psychiatry and neurology, this work introduces a practical, physiological biomarker that could transform cognitive assessment protocols. Integrating pupil dilation measurement into clinical practice may enable earlier detection of cognitive decline and more sensitive monitoring of treatment responses in conditions like MCI and dementia. This objective measure can complement subjective reports and standard neuropsychological testing, potentially improving diagnostic accuracy and personalizing patient care strategies in mental health and neurocognitive disorders.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
